Frederick Luk

1.8k total citations
16 papers, 1.5k citations indexed

About

Frederick Luk is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Frederick Luk has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Frederick Luk's work include RNA Interference and Gene Delivery (8 papers), Extracellular vesicles in disease (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). Frederick Luk is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Extracellular vesicles in disease (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). Frederick Luk collaborates with scholars based in Australia, United Kingdom and United States. Frederick Luk's co-authors include Mary Bebawy, Richard Callaghan, Ritu Jaiswal, Rebecca S. Mason, Ching‐Yee Loo, Ramin Rohanizadeh, Wing‐Hin Lee, Georges E. Grau, Joyce Gong and Ariane Roseblade and has published in prestigious journals such as PLoS ONE, Molecular Cancer and European Journal of Pharmacology.

In The Last Decade

Frederick Luk

16 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederick Luk Australia 15 897 402 371 306 177 16 1.5k
Mysore S. Veena United States 19 944 1.1× 327 0.8× 308 0.8× 848 2.8× 168 0.9× 28 1.9k
Mara C. Ebeling United States 21 978 1.1× 168 0.4× 298 0.8× 249 0.8× 292 1.6× 33 1.7k
Sita Aggarwal United States 16 834 0.9× 233 0.6× 281 0.8× 432 1.4× 87 0.5× 27 1.4k
Amit Deorukhkar United States 18 953 1.1× 349 0.9× 263 0.7× 300 1.0× 253 1.4× 34 1.8k
Béla Ózsvári United Kingdom 26 1.2k 1.4× 635 1.6× 542 1.5× 75 0.2× 142 0.8× 40 2.3k
Farid Hashemi Iran 27 1.5k 1.7× 870 2.2× 356 1.0× 199 0.7× 338 1.9× 40 2.4k
Chengguang Zhao China 25 1.0k 1.1× 281 0.7× 500 1.3× 406 1.3× 69 0.4× 47 1.9k
Satish Ramalingam United States 21 1.0k 1.1× 421 1.0× 367 1.0× 73 0.2× 86 0.5× 65 1.7k
Elif Damla Arısan Türkiye 23 756 0.8× 332 0.8× 229 0.6× 125 0.4× 83 0.5× 91 1.4k

Countries citing papers authored by Frederick Luk

Since Specialization
Citations

This map shows the geographic impact of Frederick Luk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick Luk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick Luk more than expected).

Fields of papers citing papers by Frederick Luk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick Luk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick Luk. The network helps show where Frederick Luk may publish in the future.

Co-authorship network of co-authors of Frederick Luk

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick Luk. A scholar is included among the top collaborators of Frederick Luk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick Luk. Frederick Luk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Krishnan, Sabna Rajeev, Frederick Luk, Ross Brown, et al.. (2016). Isolation of Human CD138+ Microparticles from the Plasma of Patients with Multiple Myeloma. Neoplasia. 18(1). 25–32. 53 indexed citations
2.
Krishnan, Sabna Rajeev, Ritu Jaiswal, Ross Brown, Frederick Luk, & Mary Bebawy. (2016). Multiple myeloma and persistence of drug resistance in the age of novel drugs (Review). International Journal of Oncology. 49(1). 33–50. 29 indexed citations
3.
Roseblade, Ariane, Frederick Luk, Alison T. Ung, & Mary Bebawy. (2015). Targeting Microparticle Biogenesis: A Novel Approach to the Circumvention of Cancer Multidrug Resistance. Current Cancer Drug Targets. 15(3). 205–214. 45 indexed citations
4.
Gong, Joyce, et al.. (2015). Microparticles in cancer: A review of recent developments and the potential for clinical application. Seminars in Cell and Developmental Biology. 40. 35–40. 62 indexed citations
5.
Gong, Joyce, Frederick Luk, Ritu Jaiswal, & Mary Bebawy. (2014). Microparticles Mediate the Intercellular Regulation of microRNA-503 and Proline-Rich Tyrosine Kinase 2 to Alter the Migration and Invasion Capacity of Breast Cancer Cells. Frontiers in Oncology. 4. 220–220. 33 indexed citations
6.
Pokharel, Deep, Matthew P. Padula, Jamie F. Lu, et al.. (2014). Proteome analysis of multidrug‐resistant, breast cancer–derived microparticles. Journal of Extracellular Vesicles. 3(1). 45 indexed citations
7.
Callaghan, Richard, Frederick Luk, & Mary Bebawy. (2014). Inhibition of the Multidrug Resistance P-Glycoprotein: Time for a Change of Strategy?. Drug Metabolism and Disposition. 42(4). 623–631. 363 indexed citations
8.
Lee, Wing‐Hin, Mary Bebawy, Ching‐Yee Loo, et al.. (2014). Fabrication of Curcumin Micellar Nanoparticles with Enhanced Anti-Cancer Activity. Journal of Biomedical Nanotechnology. 11(6). 1093–1105. 74 indexed citations
9.
Jaiswal, Ritu, et al.. (2013). Breast Cancer-Derived Microparticles Display Tissue Selectivity in the Transfer of Resistance Proteins to Cells. PLoS ONE. 8(4). e61515–e61515. 92 indexed citations
10.
Gong, Joyce, Frederick Luk, Ritu Jaiswal, et al.. (2013). Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance. European Journal of Pharmacology. 721(1-3). 116–125. 67 indexed citations
11.
Lee, Wing‐Hin, Ching‐Yee Loo, Mary Bebawy, et al.. (2013). Curcumin and its Derivatives: Their Application in Neuropharmacology and Neuroscience in the 21st Century. Current Neuropharmacology. 11(4). 338–378. 419 indexed citations
12.
Bebawy, Mary, Ariane Roseblade, Frederick Luk, et al.. (2013). Cell-Derived Microparticles: New Targets in the Therapeutic Management of Disease. Journal of Pharmacy & Pharmaceutical Sciences. 16(2). 238–238. 43 indexed citations
13.
Lu, Jamie F., Frederick Luk, Joyce Gong, et al.. (2013). Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways. Pharmacological Research. 76. 77–83. 71 indexed citations
14.
Jaiswal, Ritu, et al.. (2012). Microparticle conferred microRNA profiles - implications in the transfer and dominance of cancer traits. Molecular Cancer. 11(1). 89 indexed citations
15.
Luk, Frederick, Yan Yu, William R. Walsh, & Jialin Yang. (2011). IGF1R-Targeted Therapy and Its Enhancement of Doxorubicin Chemosensitivity in Human Osteosarcoma Cell Lines. Cancer Investigation. 29(8). 521–532. 28 indexed citations
16.
Luk, Frederick, et al.. (2011). New gene groups associated with dissimilar osteoblastic differentiation are linked to osteosarcomagenesis.. PubMed. 8(2). 65–75. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026